Tuesday, February 27, 2024

After-hours movers: AT&T, Tesla, DocuSign and more

Must read

Offerpad narrows Q4 loss, expects to be back in black later this year

The iBuyer expects to sell between 750 and 850 homes during Q1 2024, generate $245 million to $285 million in revenue and...

Institutional investors are scooping up Kiavi’s ‘fix and flip’ bridge loans

Kiavi upsizes its 16th securitization to $350 million and says largest deal since November 2021 brings total issuance since 2019 to $4...

With $15M goal, Knock turns to ‘everyday’ investors

Alternative financing company Knock has secured $10 million from Second Century Ventures, the venture capital arm of the National Association of Realtors,...

Star broker Jaime Richichi moves to Sotheby’s International Realty

NYC Compass broker Jaime Richichi is taking her talents to Sotheby’s International Realty. Richichi’s home base will be SIR’s East Side Manhattan...

After-hours movers: AT&T, Tesla, DocuSign and more © Reuters. After-hours movers: AT&T, Tesla, DocuSign and more

After-Hours Stock Movers:

AT&T (NYSE:) stock climbed 1.1%, paring an intraday loss of 3.75% after investors were spooked by concerns about liability over lead-sheathed phone cables. According to the Wall Street Journal, the EPA recently asked telecom executives to meet with the agency about the cables. Peer Verizon (NYSE:) was lower by 3% during the regular session.

Tesla (NASDAQ:) was lower by 0.4% after earlier falling 2.9%. According to Reuters, the EV maker will suspend most car production at its factory near Berlin from Jan. 29 to Feb. 11 do to a lack of components because of attacks on vessels in the Red Sea.

DocuSign Inc . (NASDAQ:) was lower by 0.5%, paring a regular session gain 9.3%. The stock surged after Reuters reported that two private equity firms are vying to acquire the company.

Cytokinetics (NASDAQ:) shares climbed 1% after plunging 16% intraday on concerns a deal for the late-stage biopharmaceutical company won’t materialize after interest from Novartis (NVS) cooled. An agreement with Novartis was expected as soon as this week but the drug giant backed away in recent days, according to Wall Street Journal sources.

Flexsteel Industries (FLXS) stock gained 11% after it announced preliminary second quarter sales of $100.1 million compared to $93.1 million in the prior year quarter. Third quarter sales are expected to grow 2% to 7% year-over-year to $101 million to $106 million.

By Louis Juricic

More articles

Latest article

Offerpad narrows Q4 loss, expects to be back in black later this year

The iBuyer expects to sell between 750 and 850 homes during Q1 2024, generate $245 million to $285 million in revenue and...

Institutional investors are scooping up Kiavi’s ‘fix and flip’ bridge loans

Kiavi upsizes its 16th securitization to $350 million and says largest deal since November 2021 brings total issuance since 2019 to $4...

With $15M goal, Knock turns to ‘everyday’ investors

Alternative financing company Knock has secured $10 million from Second Century Ventures, the venture capital arm of the National Association of Realtors,...

Star broker Jaime Richichi moves to Sotheby’s International Realty

NYC Compass broker Jaime Richichi is taking her talents to Sotheby’s International Realty. Richichi’s home base will be SIR’s East Side Manhattan...

Should you leave your brokerage? 5 questions to ask yourself first

Should you tough it out at your current brokerage or risk the unknown by leaving? Milena Monet shares questions to ask yourself...